Clinical Progression on CDR-SB © : Progression Free Time at Each 0.5-unit Level in Dominantly Inherited and Sporadic Alzheimer’s Disease Populations is a research paper published in medRxiv (2025). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 3R01AG062687-01S1
(-)-Phenserine inhibition of neuronal death in Alzheimer’s disease and developing brain-labeled plasma exosomes assays as biomarkers for a phenserine phase 1b ascending dose trial
National Institutes of Health
Grant: 5R01AG055444-05
Alzheimer's Prevention Initiative ADAD Colombia Trial
Canadian Institutes of Health Research
Grant: unidentified
unidentified
National Institutes of Health
Grant: 1R01AG068319-01
DIAN-TU: Tau Next Generation Prevention Trial
National Institutes of Health
Grant: 5R01AG046179-02
Dominantly Inherited Alzheimer's Network Trials Unit - Adaptive Prevention Trial
National Institutes of Health
Grant: 1U01AG024904-01
Alzheimers Disease Neuroimaging Initiative
National Institutes of Health
Grant: 1R01AG054434-01A1
The delivery of essential fatty acids to the Brain in Alzheimer's disease
National Institutes of Health
Grant: 3R01AG074983-02S1
Manufacturing of New Batch AV-1959D Drug Product and Placebo for Phase 1 Trial
National Institutes of Health
Grant: 3U01AG052564-02S2
Mapping the Human Connectome During Typical Aging
National Institutes of Health
Grant: 5R01AG053267-02
DIAN-TU: Next Generation Prevention Trial
National Institutes of Health
Grant: 3P30AG066530-04S1
Alzheimer Disease Research Center
National Institutes of Health
Grant: 5R01AG051346-03
Novel Cognitive and Functional Measure for Alzheimer's Disease Prevention Trials
National Institutes of Health
Grant: 5R01AG063826-04
Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical Trial
National Institutes of Health
Grant: 5U01AG059798-03
DIAN-TU Primary Prevention Trial
National Institutes of Health
Grant: 5U19AG032438-03
DIAN Genetics Core
National Institutes of Health
Grant: 3U01AG042791-02S1
DOMINANTLY INHERITED ALZHEIMER NETWORK TRIAL: AN OPPORTUNITY TO PREVENT DEMENTIA
Fields of Study
Keywords